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Cell membrane association by several important
peripheral proteins, such as Src, MARCKS, HIV-1 Gag, and
K-Ras, requires nonspecific electrostatic interactions
between a cluster of basic residues on the protein and
acidic phospholipids in the plasma membrane. A simple
theoretical model based on the nonlinear
Poisson–Boltzmann equation describes well the
experimentally measured electrostatic association
between such proteins and the cell membrane.
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Hydrophobic and electrostatic interactions act in concert to
anchor to cell membranes several important proteins that
are either myristoylated (e.g. Src, HIV-1 Gag and myristoy-
lated alanine-rich C kinase substrate, MARCKS) or farnesy-
lated (e.g. K-Ras). Two recent reviews focused on how the
attachment of acyl and isoprenyl groups to proteins influ-
ences their association with membranes [1,2]. Here, we
consider the role electrostatic interactions play in enhancing
the partitioning of myristoylated proteins onto membranes,
using the proto-oncogene product c-Src as an example [1,3]. 
Figure 1 shows the domain organization of the tyrosine
kinase c-Src. Recent structural studies have revealed how
the intramolecular binding of a C-terminal phosphorylated
tyrosine (Tyr527) to the SH2 domain juxtaposes the SH3
domain with the polyproline type-II helix that links the
SH2 and kinase domains [3]. The intramolecular interac-
tion between the SH3 and kinase domains maintains the
protein in an inactive conformation. Because the viral, onco-
genic version, v-Src, lacks the C-terminal tyrosine, it is con-
stitutively active. The N-terminal portion was not included
in the recently determined crystal structure of Src [3]. This
region contains the two motifs required for membrane asso-
ciation (shown in Figure 1a) — the myristate (colored
green) and a cluster of basic residues (blue plus signs),
which are shown in more detail in Figure 1b. Membrane
binding increases the effective concentration of Src in a thin
(d ~1 nm) surface layer adjacent to the membrane. For a
spherical cell with a radius r equal to a few micrometers, the
volume of the surface phase (V = 4pir2d) is about 1/1000 the
volume of the cell (V = 4pir3/3); thus, anchoring Src to the
membrane increases its effective concentration 1000-fold,
thereby greatly enhancing its ability to phosphorylate its
membrane-bound substrates.
Two factors contribute to Src membrane binding
Myristate (14-carbon fatty acid) is attached cotranslation-
ally through an amide bond to the N-terminal glycine of
Src by the enzyme N-myristoyl transferase [1,2]. Myristate
is required for Src membrane binding which, in turn, is
required for Src to function — nonmyristoylated v-Src
mutants are found in the cytoplasm and do not transform
cells, even though the kinase activity of the protein is
unaffected [1,4,5]. Small myristoylated peptides bind to
electrically neutral phospholipid vesicles with a unitary
binding energy of 8 kcal/mol (or a molar partition coeffi-
cient of 104 M–1) [6,7]. Measurements of the membrane
partitioning of acylated peptides show that the binding
energy increases 0.8 kcal/mol for each CH2 group added
to the acyl chain [6], which is in agreement with measure-
ments of the hydrophobic partitioning of fatty acids into
oil from water [8]. The model in Figure 1 is consistent with
these results: 8 kcal/mol ÷ 0.8 kcal/mol per CH2 = 10 CH2
groups, which  penetrate the hydrocarbon core of the
membrane; the remaining four traverse the polar head
group region and the N-terminal glycine is located just
outside the envelope of the polar head group region (Fig-
ure 1b). Monolayer and circular dichroism measurements
[7] and, more importantly, direct structural electron para-
magnetic resonance (EPR) measurements of spin-labeled
peptides (D Cafiso, personal communication) confirm that
the N-terminal residues of Src do not penetrate the mem-
brane and indicate that the peptide has an extended con-
formation, as illustrated in Figure 1. 
Although myristate is required for Src membrane binding,
when alone it is not sufficient to anchor Src to its target
membranes [1,2,9]. The Src protein partitions onto electri-
cally neutral membranes with a molar partition coefficient
of 103 M–1 [10]; the concentration of lipid in the plasma
membrane of a cell of 10 µm radius is about 10–3 M, so
myristate alone would anchor only half of the number of
protein molecules to the membrane. As discussed else-
where [1,2], other Src family kinases (e.g. Lck and Fyn)
augment the binding due to myristate with an N-terminal
palmitate (16-carbon fatty acid). Src, in contrast, has an N-
terminal cluster of basic residues. Studies with peptides
corresponding to the N terminus of Src show that adding
33% acidic lipid to electrically neutral membranes increases
the binding 1000-fold [7]. The same 1000-fold enhance-
ment is seen with the intact Src protein [10]. Mutations that
remove the N-terminal basic residues weaken the partition-
ing of Src onto phospholipid vesicles containing acidic
lipids and produce non-transforming phenotypes in living
cells [1,10,11]. These observations provide strong evidence
that the N-terminal basic residues contribute to the mem-
brane binding of Src by interacting electrostatically with
acidic lipids.
Energetics of membrane binding
To a first approximation, the hydrophobic and electrosta-
tic binding energies can be added together to give the
total binding energy of Src (or the molar partition coeffi-
cients can be multiplied). This observation follows from
models that consider the acyl chain and basic cluster as
points connected by a flexible string of length L [7,12].
Binding of myristate to the membrane confines the basic
cluster to a hemisphere of radius L above the membrane
surface and facilitates its adsorption to the membrane. Al-
though these simple models account for the synergism
between electrostatic and hydrophobic interactions, they
are descriptive rather than predictive. Using atomic models
of Src’s N terminus and phospholipid bilayers (Figure 1)
and a continuum representation of the solvent [13,14], we
can predict the electrostatic partitioning by solving the
nonlinear Poisson–Boltzmann equation [15,16]. This mean
field theory ignores ion–ion correlation effects and the
finite size of ions in the aqueous phase; theoretical work
has justified these assumptions for physiological condi-
tions [17]. The assumption that water molecules adjacent
to a membrane can be treated theoretically as a dielectric
continuum is supported by surface force, X-ray diffraction
and other experiments [18]. The theoretical methods accu-
rately describe the electrostatic potentials adjacent both to
proteins [13] and to phospholipid bilayers [19]. 
We illustrate the theoretical model by considering the
interaction of a nonmyristoylated (nonmyr) peptide corre-
sponding to the N terminus of Src, nonmyr-Src(2–19), with
a phospholipid membrane containing 33% acidic lipid in
100 mM salt solution. The peptide is docked in the aque-
ous solution above the membrane (e.g. in an orientation
similar to that depicted in Figure 1). Each atom is assigned
a radius and a partial charge, and the peptide–membrane
model is mapped onto a three-dimensional lattice of points
[20]. The nonlinear Poisson–Boltzmann equation is solved
numerically [20] for the electrostatic potential due to the
peptide and the membrane when they are far apart and
when they are close together, as described by Ben-Tal et al.
[15]. These potentials are used to calculate the changes in
the electrostatic free energy as the peptide approaches the
membrane [21]. Figure 2a shows the electrostatic free
energy of interaction as a function of the distance R be-
tween the van der Waals surfaces of the peptide and
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Domain structure of c-Src. (a) Cartoon (approximately to scale)
illustrating the domain structure of c-Src as determined by recent
X-ray crystallographic analysis [3]. See text for details. (b) Exploded
view of Src’s N terminus interacting with a 2:1 phosphatidylcholine:
phosphatidylserine membrane. The conformation of Src(2–19),
myristate–GSSKSKPKDPSQRRRSLE, is consistent with
experimental measurements (see text). The myristate is colored
green, basic residues blue and acidic residues red. In the membrane,
the acidic lipid, phosphatidylserine, is identified by its exposed
nitrogen, colored blue.
membrane. The free energy curve illustrates the long-
range Coulombic attraction and short-range Born repulsion
(i.e. the free energy cost of desolvating charged and polar
groups) that result in the free energy minimum at R ~3 Å.
The peptide concentration at each distance R (Figure 2b)
is a product of the peptide concentration at infinity (in the
bulk solution) and the exponent of the interaction energy.
(In practice, the peptide concentration at R is calculated by
averaging over many orientations of the peptide with
respect to the membrane in order to approximate a com-
plete ensemble of different configurations) Integrating the
excess peptide concentration over R (grey area in
Figure 2b) gives the Gibbs surface excess, which repre-
sents the number of moles of peptide bound per unit area
of membrane surface. The Gibbs surface excess is simply
related to the molar partition coefficient that is measured
experimentally [15]. As illustrated in Figure 2b, the bound
peptides, which associate with the membrane through
long-range electrostatic interactions, can be located at an
appreciable distance from the membrane surface (e.g. a sig-
nificant amount of peptide is bound at R = 5 Å). This is
consistent with experimental results that show the binding
of model peptides to membranes depends only weakly on
the chemical nature of either the basic residues or the
monovalent acidic lipid [15]. As discussed in detail else-
where, this nonspecific association is more accurately
described by a partition coefficient [6,16,22] rather than by
a binding constant which assumes the formation of a 1:1
complex between protein and membrane lipid (as is seen,
for example, with the binding of phosphatidylinositol 4,5-
bisphosphate (PIP2) to the pleckstrin homology domain of
phospholipase C-δ1 [23]). 
This theoretical methodology has been used to describe
the membrane partitioning of basic peptides [15], charyb-
dotxin and its analogs [16], and Src(2–19) (DM, NB, BH
and SM, unpublished results) — the model correctly pre-
dicts how the binding is affected by changes in the ionic
strength of the solution, the net positive charge of the
peptide or the mole % acidic lipid in the membrane. For
example, the model predicts that the binding of charybdo-
toxin (net charge +4) decreases by five orders of magnitude
when the salt concentration is increased from 10 mM to
150 mM, in agreement with the measured partitioning
[16]. The results of these studies indicate that the model
describes well the long-range (R ≥ 3 Å) electrostatic attrac-
tion that gives rise to the membrane binding. Neverthe-
less, the calculated binding energies based on electrostatics
alone consistently underestimate the observed values by
1–2 kcal/mol. This implies that the model ignores some
attractive interactions [16], overestimates the repulsive
interactions, or both. Further theoretical and experimental
work, such as that previously described [16,24,25], is
required to obtain a more accurate description of the short-
range (R < 3 Å) interactions, particularly when hydrophobic
residues penetrate the polar head group region. 
Acyl groups and basic clusters: other proteins, other
functions 
Other proteins that use either myristate or farnesyl groups
and a cluster of basic residues to bind to membranes in-
clude HIV-1 Gag [26], K-Ras 4B [27] and MARCKS [28,
29] (Figure 3). The N-terminal cleavage product of HIV-1
Gag, the viral matrix protein, contains the protein’s two
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Figure 2
Membrane electrostatics. (a) Electrostatic free energy curve. The
electrostatic free energy of the interaction between nonmyristoylated
(nonmyr)-Src(2–19) and a 2:1 phosphatidylcholine: phosphatidylserine
lipid bilayer in 100 mM monovalent salt as a function of the distance R
between the van der Waals surfaces of the peptide and the membrane
(DM, NB, BH and SM, unpublished calculations). See Ben-Tal et al.
[15] for theoretical methods. (b) The concentration of nonmyr-
Src(2–19), [P(R)], as a function of the distance R. The bulk peptide
concentration, [P(∞)], is chosen as 1 µM to match the experimental
conditions [7]. The Gibbs surface excess is defined as the integral of
[P(R)]–[P(∞)] over distance R . This quantity, the grey area in the
figure, may be considered as the number of moles of nonmyr-
Src(2–19) adsorbed per unit area of membrane surface.
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membrane-binding motifs [26]. Structural studies of the
HIV-1 matrix protein show the basic residues, in contrast
to the extended conformation of Src’s N-terminus, are
clustered into a β-sheet region that forms a membrane-
binding surface [30]. K-Ras, a small GTPase, uses farnesyl
(a 15-carbon isoprenoid) rather than myristate to bind to
membranes. The farnesyl chain, like myristate, does not
provide sufficient hydrophobic energy to anchor the pro-
tein to membranes [31]. Adding 20% acidic lipid to electri-
cally neutral membranes enhances the binding of farnesy-
lated peptides corresponding to the C terminus of K-Ras
300-fold [12]. Although separated by 150 residues, both
the N-terminal myristate and the cluster of basic residues
are required for the membrane anchoring of MARCKS
[2,9, 28,29]. EPR measurements of 15 spin-labeled peptides
corresponding to the basic effector region of MARCKS,
MARCKS (151–175), showed that the peptide lies at the
membrane interface in an extended conformation with its
five phenylalanines penetrating the polar head group
region [32]. MARCKS is interesting because protein kin-
ase C (PKC) catalyzed phosphorylation of three serines
within the basic effector region weakens the electrostatic
interaction and causes the MARCKS protein to translocate
from the plasma membrane to the cytoplasm in many cell
types [33]; this mechanism has been termed the ‘myris-
toyl–electrostatic’ switch [1,2,9]. Other myristoylated pro-
teins use a different switch mechanism, the ‘myristoyl–
ligand’ switch [1,2], for reversible membrane binding; for
example, recoverin binds to membranes when its seques-
tered myristate moiety is exposed in response to Ca2+ [34].
Other lipid-modified proteins have clusters of basic
residues that may interact with acidic lipids: for example,
endothelial nitric-oxide synthase (eNOS) [35,36], diacyl-
glycerol kinase ζ [37], GAP–43/neuromodulin [38], Src-
suppressed C kinase substrate (SSeCKS) [39], some G-
protein coupled receptor kinase (GRK) family members
[40], the heterotrimeric G-protein subunit α12 (TLZ
Jones, personal communication) and Rho family GTPases
[41]. As an aside, we note that myristate and clusters of
basic residues are not always involved in membrane
binding — cAMP-dependent protein kinase, for example,
keeps its myristate permanently tucked away in a hydro-
phobic cleft, and many proteins use clusters of basic resi-
dues as nuclear localization signals. 
In addition to attaching proteins to membranes, acyl
chains and clusters of basic residues may direct periph-
eral proteins to lateral domains in the plasma membrane.
Many important signaling molecules (e.g. Src family
members Lck and Fyn, some G-protein alpha subunits,
H-Ras, eNOS and PIP2) are concentrated in plasma mem-
brane organelles called caveolae [42]. Src, PKCα, SSeCKS
and focal adhesion kinase are co-localized with cyto-
skeletal elements in focal adhesion plaques [39,43].
MARCKS has a punctate distribution in the plasma
membrane of macrophages and is concentrated, with
PKCα, in nascent phagosomes [44]. In phospholipid
vesicles, the basic effector region of MARCKS forms
discrete lateral domains enriched in monovalent acidic
phospholipids and PIP2, as visualized by digital imaging
fluorescence microscopy [45]. Similar results are ob-
tained with the simpler basic peptide pentalysine [45],
the domains of which have also been observed using
magic angle spinning NMR (G Gröbner and A Watts,
personal communication). The results indicate that electro-
static interactions can play a major role in lateral domain
formation in membranes, and that PIP2 can be reversibly
sequestered in domains by nonspecific electrostatic inter-
actions [45], a phenomenon with interesting biological
implications. In summary, hydrophobic and electrostatic
interactions act synergistically to anchor several im-
portant myristoylated and farnesylated proteins to mem-
branes; the electrostatic interactions can be described
well using simple physical models.
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